Inhibition of PFKFB3 by PFK158 reduced the levels of several stemness markers, such as CD133 and SOX2; impeded glycolysis; and attenuated tumor growth in SCLC cell line-derived xenografts. Here, PFKFB3 is linked to small cell lung carcinoma.